1. Academic Validation
  2. Synthesis of novel tricyclic chromenone-based inhibitors of IRE-1 RNase activity

Synthesis of novel tricyclic chromenone-based inhibitors of IRE-1 RNase activity

  • J Med Chem. 2014 May 22;57(10):4289-301. doi: 10.1021/jm5002452.
Sujeewa Ranatunga 1 Chih-Hang Anthony Tang Chang Won Kang Crystina L Kriss Bernhard J Kloppenburg Chih-Chi Andrew Hu Juan R Del Valle
Affiliations

Affiliation

  • 1 Drug Discovery Department and ‡Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute , 12902 Magnolia Drive MRC3E, Tampa, Florida 33612, United States.
Abstract

Inositol-requiring Enzyme 1 (IRE-1) is a kinase/RNase ER stress sensor that is activated in response to excessive accumulation of unfolded proteins, hypoxic conditions, calcium imbalance, and other stress stimuli. Activation of IRE-1 RNase function exerts a cytoprotective effect and has been implicated in the progression of Cancer via increased expression of the transcription factor XBP-1s. Here, we describe the synthesis and biological evaluation of novel chromenone-based covalent inhibitors of IRE-1. Preparation of a family of 8-formyltetrahydrochromeno[3,4-c]pyridines was achieved via a Duff formylation that is attended by an unusual cyclization reaction. Biological evaluation in vitro and in whole cells led to the identification of 30 as a potent inhibitor of IRE-1 RNase activity and XBP-1s expression in wild type B cells and human mantle cell lymphoma cell lines.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-107400
    98.69%, IRE1 Inhibitor